XERS- Xeris Biopharma Holdings, Inc.

Name: Xeris Biopharma Holdings, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Xeris Biopharma Holdings, Inc. (XERS) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. XERS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Shannon John Patrick Jr	3.16M	$20.16M	-
Other	McCulloch Kevin	1.79M	$11.40M	-
Other	Pieper Steven	1.46M	$9.33M	-
Other	Hecht Beth	1.19M	$7.62M	-16,667
Dir	Johnson John	698.1K	$4.46M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 1, 2026	Hecht Beth45	See Remarks	Sell	16,667	$6.23	$103,805.41	-1.4%	-	-
Feb 2, 2026	Hecht Beth45	See Remarks	Sell	16,667	$7.45	$124,147.48	-1.3%	-14.7%	-
Jan 8, 2026	McCulloch Kevin	See Remarks	Sell	15,000	$8.00	$120,000.00	-0.9%	-27.2%	-
Jan 5, 2026	Shannon John Patrick Jr53	See Remarks	Sale+OE	24,907	$7.08	$176,256.88	-0.9%	-14.7%	-
Jan 2, 2026	Hecht Beth45	See Remarks	Sell	16,667	$7.43	$123,775.81	-1.3%	-17.8%	-
Dec 19, 2025	Johnson John49	Director	Sell	135,400	$7.22	$977,019.32	-16.2%	-24.0%	-
Dec 12, 2025	Bormann-Kennedy Barbara-Jean Anne	Director	Sell	15,000	$7.09	$106,414.50	-9.5%	-23.6%	-
Dec 1, 2025	Hecht Beth45	See Remarks	Sell	16,667	$7.01	$116,780.67	-1.2%	-13.5%	-
Nov 13, 2025	Shannon John Patrick Jr53	See Remarks	Sale+OE	23,242	$7.46	$173,401.59	-0.9%	-4.8%	-
Nov 11, 2025	Hecht Beth45	See Remarks	Sell	16,667	$7.40	$123,295.80	-1.2%	-6.5%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC